Inventor
CHEN WEIZAO
US13 patents
⚠️ This page may combine multiple inventors who share the name “CHEN WEIZAO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
US HEALTH
6 patentsUS10287340B2May 14, 2019
Anti-HIV domain antibodies and method of making and using same
US HEALTH1 citations62
US10472412B2Nov 12, 2019
Bispecific multivalent fusion proteins
US HEALTH1 citations60
US12012455B2Jun 18, 2024
Human monoclonal antibodies specific for FLT3 and uses thereof
US HEALTH0 citations57
US11236171B2Feb 1, 2022
Human monoclonal antibodies specific for FLT3 and uses thereof
US HEALTH0 citations57
US9657096B2May 23, 2017
Human domain antibodies against components of the human insulin-like growth factor (IGF) system
US HEALTH0 citations51
US10647754B2May 12, 2020
Stabilized single human CD4 domains and fusion proteins
US HEALTH0 citations48
DIMITROV DIMITER S
3 patentsUS9181327B2Nov 10, 2015
Anti-HIV domain antibodies and method of making and using same
DIMITROV DIMITER S9 citations83
US8911728B2Dec 16, 2014
High-affinity fully functional soluble single-domain human CD4, antibodies, and related fusion proteins
DIMITROV DIMITER S16 citations83
US9056907B2Jun 16, 2015
Human domain antibodies against components of the human insulin-like growth factor (IGF) system
DIMITROV DIMITER S0 citations51
ZHEJIANG SHIMAI PHARMACEUTICAL CO LTD
3 patentsUS12325757B2Jun 10, 2025
Protease cleavable bispecific antibodies and uses thereof
ZHEJIANG SHIMAI PHARMACEUTICAL CO LTD0 citations58
US12325758B2Jun 10, 2025
Protease cleavable bispecific antibodies and uses thereof
ZHEJIANG SHIMAI PHARMACEUTICAL CO LTD0 citations58
US11339218B2May 24, 2022
Human monoclonal antibodies against LAG3 and uses thereof
ZHEJIANG SHIMAI PHARMACEUTICAL CO LTD1 citations58